Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment

PRESS RELEASES HONG KONG–(BUSINESS WIRE)– Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), today announced that Regencell Bioscience Limited (“Regencell HK”), the Company’s wholly-owned subsidiary in Hong Kong, has entered into a joint venture agreement with Honor Epic Enterprises Limited (“Honor Epic”). The joint venture (“JV”) is expected to offer COVID-19 (“COVID”) related treatments to patients in ASEAN countries, India, Japan, Australia and New Zealand. […]

Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter’s Over-Allotment Option

PRESS RELEASES HONG KONG–(BUSINESS WIRE)– Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine (“TCM”) for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder (“ADHD”) and Autism Spectrum Disorder (“ASD”), today announced that the underwriter of its initial public […]

Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders

PRESS RELEASES HONG KONG–(BUSINESS WIRE)– Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company today released a letter from Yat-Gai Au, Founder and Chief Executive Officer of the Company. Dear Shareholders: As CEO of Regencell, I am pleased to take this opportunity to discuss the significant milestones we achieved thus far in 2021, […]

Regencell Bioscience Holdings Limited Announces Closing of Initial Public Offering

PRESS RELEASES HONG KONG–(BUSINESS WIRE)– Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine (“TCM”) for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder (“ADHD”) and Autism Spectrum Disorder (“ASD”), today announced the closing of its initial public […]

Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering

PRESS RELEASES HONG KONG–(BUSINESS WIRE)– Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine (“TCM”) for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder (“ADHD”) and Autism Spectrum Disorder (“ASD”), today announced the pricing of its initial public […]

Cash Donation to Iu Shan School for School Supplies

Lu Shan School

NEWS AND UPDATES Cash Donation to Iu Shan School for School Supplies We offer cash donation for Special Education Needs student from Iu Shan School. 6 students benefit from this program. (8-yoga classes including yoga matt).  Our goal is to help people unconditionally.   Click to learn more: Iu Shan School